Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Randox Laboratories Ltd.. (10/2/18). "Press Release: The Key Features and Benefits of Biochip Array Technology".

Organisation Organisation Randox Laboratories Ltd.
  Group Randox (Group)
Product Product Biochip Array Technology (Randox)

In 1992, Randox invested £180 million to create and introduce Biochip Array Technology (BAT) which converted laboratory testing. Randox came up with the innovation by recognising the major problem with traditional diagnosis. Within traditional diagnosis several tests are typically required which involves multiple blood draws from the patient, many visits to the hospital, increased reagent volume and increased time to diagnosis. Biochip Array Technology allows for the simultaneous quantitative or qualitative detection of a wide range of analytes from one single sample. Therefore, it is faster, cost saving and more effective leading to better clinical decisions. Today the technology (BAT) is used in countless laboratories worldwide and a range of three biochip analysers are now offered.

The main basis of the Biochip Array Technology

> 9x9mm biochip which acts as a solid phase reaction vessel.

> Each of the biochips are pre-coated with an array of discrete test regions (DTRs)

> One biochip per sample used to generate multiple results.

> Randox Biochips hold up to 49 tests.

> Based on chemiluminescent signal emitting light, without heat which results a chemical reaction.

The key features and benefits of the Biochip Array Technology
Highly accurate testing

> The biochip array technology provides high standard of accurate test results with CV’s <10%

> Multiplex analysis minimises analytical variation between the tests.

Better diagnosis

> Increased patient information available through testing multiple markers

> Patients receive their results quicker compared to the traditional diagnosis.

Reduced sample volume

> Reduced sample required therefore patients feel more at ease.

Wide test menu

> Wide test menu provides a variety for clients and allows flexibility.

Multiple samples

> Multiple samples can be used on BAT which include the following; serum, plasma, whole blood, urine and many others which allows for flexibility in their testing

Cost consolidation

> The process reduces the amount of time spent on individual tests and associated laboratory costs
Biochip testing platforms

Evidence Evolution

The Evidence Evolution is fully automated random-access biochip testing platform. The machine allows any test to perform at any time as it is a highly versatile analyser which can operate any workflow. It can receive 2640 tests per hour which means the machine has a fast turnaround time. As well as this, it allows multiple tests to be performed from a single sample which reduces time and resources spent on individual tests. The Evidence Evolution can be tailored to certain laboratory needs and have features including automatic start-up and shut down, relaxed testing capability and traceability of biochips. The equipment overall is made to be easy for the client to use as it includes customisable user settings and easy to follow result screens giving them the fast and accurate operations they would prefer.


The Evidence Analyser is the protein Biochip Array technology. Like the Evidence Evolution it is fully automated which is suitable for busy laboratories, hospitals, forensic and clinical toxicology. The machine is floor standing and can receive up to 3690 per hour. The machine has features such as easy to follow software and customisable user settings which gives laboratories the opportunity to receive fast and accurate results.

Evidence investigator

The Evidence Investigator is often used for research, clinical, forensic, molecular and veterinary testing. The machine is semi-automated and can combine immunoassay and molecular diagnostics on a single platform with protein and DNA biochips. This machine also has a quick turnaround time with the ability to achieve 2376 tests per hour with 44 analytes screened per biochip. The evidence investigator provides more tests on the test menu which allows variety.

Evidence MultiSTAT

The final platform is the Evidence MultiSTAT. The Evidence MultiSTAT is a fully-automated analyser which provides quality results. It is a simple and easy to use analyser which requires minimal training with only three steps to complete the process. The machine can provide multiplex testing yields up to 46 results in under ten minutes. It is ease-of-use for non-laboratory staff and provides full traceability of user action with password controlled software.

For more information on our Biochip Array Technology contact the Randox Biosciences team by emailing

Record changed: 2018-11-16


Picture [iito] Plain Stupid Simple 650x80px

More documents for Randox (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top